IT & biopharma cooperation: High demand for funding in the second application phase

CyberForum 24.11.2017

Six months after the start of the call for applications, the project consortium was able to present a positive picture: the PERMIDES project, which is funded by the European Union under the Framework Programme Horizon 2020, has aroused great interest in both the biopharmaceutical and IT sector. By the deadline in mid-October in total 120 applications for innovative projects, each involving one biopharma SME and at least one IT SME had been received with a total requested funding amount of EUR 6.5 m. At the same time, consultancy vouchers totaling approximately EUR 215.000 and travel vouchers for selected matchmaking events with a total value of almost EUR 40.000 had been issued. After the projects of the first round have already been evaluated and funded, the evaluation of the last submissions is now starting.

PERMIDES aims to increase the innovation capability of small to medium-sized enterprises (SMEs) in the biopharma sector by means of innovation projects conducted in partnership with IT companies. These innovation projects have the objective of digitizing the value chains in the biopharma sector with the aid of IT SMEs. Funding of up to EUR 60,000 is available for each biopharma SME. Depending on the project budget, this can mean subsidies of up to 100% are granted, and for SMEs in particular this is seen as a decisive advantage over other funding schemes.

Subsidized consultancy as a stimulus

An additional element are consultancy vouchers for up to EUR 5,000 each. Biopharma SMEs requiring consulting services from IT SMEs can apply for subsidies of up to EUR 12,000 for various consulting services. Unlike the abovementioned innovation vouchers, the application and assessment process for these vouchers is continuous. Consultancy Voucher applications can be submitted anytime until November 15th 2017. On average, approval of a grant is given approximately one week following receipt of the application. This short processing period and the straightforward application procedure are further factors in the overall success of PERMIDES. As before, part of the project budget also goes towards mentoring and coaching activities offered to SMEs by the participating clusters.

Innovation project outcome presented in Berlin

Although the application phase for innovation vouchers is closed now, the project supports cooperation between IT and  biopharma sector on several events all across Europe.

On 8th of November 2017 GoSilico presented joint work with Cevec Pharmaceuticals GmbH at BioEurope in Berlin, Germany. In his presentation, Thiemo Huuk outlined the recently started cooperation project on modeling the purification of virus-like particles (VLPs).

Thiemo’s talk was part of the session “Advancing precision medicine via novel digital solutions” hosted by the EU Horizon 2020 project PERMIDES. “It was a great pleasure to be a part of this extremely interesting session”, so Thiemo Huuk. The session focused on digitalized health care and included a wide range of topics from apps improving communication between patient and doctor, up to bioinformatics approaches towards personalized drugs.

“BioEurope is one the most renowned partnering events in the field of pharma in Europe. I was impressed of the numerous opportunities to connect to industrial decision makers and the positive feedback about our chromatography simulation technology.”

Europäische Union

PERMIDES has received funding from the European Union's Horizon 2020 research and Innovation programme under grant Agreement No 691546.